000			03690nam a2200445 i 4500
999			_c362687 _d362687 _x1
001			362687
003			ES-MaUEC
005			20230102121605.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			210828s2021 si | o |||| 0|eng d
020			_a9789811639234
024	7		_a10.1007/978-981-16-3923-4 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC388.5 _b2021 EB
245	0	0	_aStroke Revisited : _bDyslipidemia in Stroke _cedited by Seung-Hoon Lee, Min Kyoung Kang
250			_aFirst edition 2021
264		1	_aSingapore _bSpringer International Publishing _c2021
300			_a1 recurso en línea (XIII, 219 páginas) _b44 ilustraciones, 38 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aArchivo de texto _bPDF
490	0		_aStroke Revisited _x2522-5596
505	0		_aPart 1 Basic Science: Dyslipidemia and Stroke -- 1 Role of Dyslipidemia in Atherosclerosis -- 2 Effects of Dyslipidemia on the Cerebral vessels -- Part 2 Clinical Significance of Dyslipidemia in Stroke -- 3 Impact of Dyslipidemia on Ischemic Stroke -- 4 Dyslipidemia and Hemorrhagic Stroke -- 5 Clinical biomarkers of Dyslipidemia. Part 3 Treatment of Dyslipidemia in Stroke Patients -- 6 Therapeutic Lifestyle Modification -- 7 Statins -- 8 Ezetimibe -- 9 Fibrate and Niacin -- 10 Fish Oils -- 11 PCSK9 inhibiting monoclonal antibodies -- 12 PCSK9 inhibiting siRNA -- 13 Understanding of Clinical Practice Guidelines for Dyslipidemia -- Part 4 Management of Dyslipidemia in Clinical Practice of Stroke -- 14 Practical Management of Dyslipidemia in Stroke Patients -- 15 Practical Dyslipidemia Management in Stroke-specific Situations -- 16 Dyslipidemia in Women: Etiology and Management -- 17 Safety Considerations of Pharmacological Treatment.
520			_aThis book presents state of the art knowledge on dyslipidemia in stroke, covering both basic and clinical aspects in detail. The focus is in particular on two major themes: the clinical significance of dyslipidemia in stroke and the treatment of dyslipidemia in stroke patients. Readers will find up-to-date information on lipid metabolism, biomarkers, and advances in treatment options, including novel biologic drugs. Specific management considerations and pitfalls are also discussed. The individual components of pathophysiology, treatment, and key issues are addressed with the aid of complementary illustrations that facilitate understanding of practical aspects and enable the reader to retrieve fundamental information quickly. This book is timely in bringing together within one volume the most important current knowledge on dyslipidemia in stroke. It will be invaluable for stroke physicians, pharmacists, and students seeking to acquire up-to-date knowledge.
988			_aSpringer_Medicine_2021
650		7	_2embne _9150775 _aEnfermedades cerebrovasculares
700	1		_aLee, Seung-Hoon _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aKang, Min Kyoung _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9789811639227
776	0	8	_iPrinted edition: _z9789811639241
776	0	8	_iPrinted edition: _z9789811639258
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-16-3923-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b02/2022 _dz _eb _zSI